Status:
COMPLETED
Predictive Genetic Risk Assessment Trial
Lead Sponsor:
Mayo Clinic
Conditions:
Colon Cancer
Lung Cancer
Eligibility:
All Genders
18-65 years
Brief Summary
This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to ...
Detailed Description
The prospect of personalized medicine is under heated debate at the Mayo Clinic and it is of interest across the world. A point of contention is the provision of individual genetic risk assessment to ...
Eligibility Criteria
Inclusion
- must be established EH patient or physician
Exclusion
- pregnant women
- patient who have already purchased Navigenics Health Compass
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00782366
Start Date
March 1 2008
End Date
January 1 2010
Last Update
April 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905